Renaissance Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
316,850
+19,313
| +6% | +$324K | 0.21% | 119 |
|
|
2025
Q1 | $4.57M | Sell |
297,537
-52,204
| -15% | -$802K | 0.2% | 105 |
|
|
2024
Q4 | $7.74M | Sell |
349,741
-20,167
| -5% | -$446K | 0.32% | 67 |
|
|
2024
Q3 | $6.67M | Sell |
369,908
-8,229
| -2% | -$148K | 0.27% | 75 |
|
|
2024
Q2 | $6.14M | Buy |
+378,137
| New | +$6.14M | 0.24% | 90 |
|
|
2016
Q4 | – | Sell |
-236,526
| Closed | -$10.9M | – | 299 |
|
|
2016
Q3 | $10.9M | Buy |
236,526
+10,659
| +5% | +$490K | 0.44% | 109 |
|
|
2016
Q2 | $11.3M | Sell |
225,867
-2,429
| -1% | -$122K | 0.48% | 101 |
|
|
2016
Q1 | $12.2M | Sell |
228,296
-3,335
| -1% | -$178K | 0.49% | 102 |
|
|
2015
Q4 | $15.2M | Sell |
231,631
-52
| -0% | -$3.41K | 0.6% | 63 |
|
|
2015
Q3 | $13.1M | Buy |
231,683
+3,244
| +1% | +$183K | 0.52% | 81 |
|
|
2015
Q2 | $13.5M | Buy |
228,439
+10,359
| +5% | +$612K | 0.52% | 93 |
|
|
2015
Q1 | $13.6M | Buy |
+218,080
| New | +$13.6M | 0.51% | 84 |
|